知镜 Cognispect · 医学文献与研究工作台

Eosinophilic Oesophagitis and Incidence of Gastrointestinal Cancer: A Population-Based Cohort Study.

Kurt G, Farkas DK, Dellon ES, Jensen ET, Sørensen HT.
Alimentary pharmacology & therapeutics · 2026-10-20 · PMID 42902446

文献摘要

Background Evidence concerning gastrointestinal cancer risk after eosinophilic oesophagitis (EoE) diagnosis is limited. Aims To examine the association between EoE and incident gastrointestinal cancer in a population-based cohort. Methods Using nationwide Danish health registries, we identified all patients diagnosed with EoE between 1997 and 2024, using a validated algorithm. We computed standardised incidence ratios (SIRs) for gastrointestinal cancers overall and site-specific cancers compared with the general population. To distinguish short-term diagnostic activity from longer-term risk, we stratified analyses by Results Among 9115 EoE patients, 170 developed gastrointestinal cancers. During the first year after EoE diagnosis, the SIR was 2.83 (95% confidence interval: 2.10-3.74). Beyond 1 year, the overall SIR attenuated (1.03 [0.85-1.23]) but remained elevated for oesophageal cancer (2.40 [1.42-3.79]) and hepatocellular carcinoma (2.05 [0.98-3.77]). Among patients who developed oesophageal cancer ≥ 1 year after EoE diagnosis (n = 18), most had prior BE. The SIR for oesophageal cancer was 5.44 (2.90-9.31) among patients with both EoE and BE and 4.84 (4.36-5.37) among patients with BE alone. SIR for patients with EoE alone could not be reported due to the low number of cancer cases. Conclusions One year after EoE diagnosis, oesophageal cancer and hepatocellular carcinoma rates remained elevated. Most oesophageal cancers occurred in patients with prior BE, suggesting that the association between EoE and oesophageal cancer may be mediated largely through BE.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。